Prostate cancer: Patient-reported outcomes of first-line abiraterone therapy

PhillipsR.

首页> 外文期刊>Nature reviews. Urology >Prostate cancer: Patient-reported outcomes of first-line abiraterone therapy

【24h】

Prostate cancer: Patient-reported outcomes of first-line abiraterone therapy

机译：前列腺癌：患者报告的一线阿比特龙治疗结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

First-line abiraterone-plus-prednisone treatment of metastatic castration-resistant prostate cancer improves patient-reported health-related quality-of-life and pain measures compared with prednisone alone for asymptomatic or mildly symptomatic men, according to a preplanned interim analysis of a phase III randomized double-blind placebo-controlled clinical trial.

机译：根据对转移性去势抵抗性前列腺癌的一线期中期分析，与仅使用泼尼松治疗的无症状或轻度症状男性相比，一线阿比特龙加泼尼松治疗可改善患者报告的与健康相关的生活质量和疼痛程度III期随机双盲安慰剂对照临床试验。

著录项

来源
《Nature reviews. Urology》 |2013年第11期|共1页
作者
PhillipsR.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Prostate cancer: Patient-reported outcomes of first-line abiraterone therapy [J] . PhillipsR. Nature reviews. Urology . 2013,第11期

机译：前列腺癌：患者报告的一线阿比特龙治疗结果
2. Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: Patient-reported outcome results of a randomised phase 3 trial [J] . BaschE., AutioK., RyanC.J., The lancet oncology . 2013,第12期

机译：初治转移性去势抵抗性前列腺癌的初治男性中醋酸阿比特龙加泼尼松与单纯泼尼松的比较：患者报告的一项随机3期试验结果
3. Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate prednisone (AA P) across Canada: Final results of COSMiC [J] . Geoffrey Gotto, Darrel E. Drachenberg, Joseph Chin, Canadian Urological Association Journal . 2020,第12期

机译：患者报告的抗阉割前列腺癌（MCRPC）患者的患者报告的结果（PROS）的现实迹象（MCRPC）治疗加拿大治疗的Abiraterone泼尼松（AA P）：宇宙的最终结果
4. Vascular-Targeted Photodynamic of Prostate Cancer Phase with Tookad for Recurrent Prostate Cancer Following Radiation Therapy: Initial Clinical Studies [C] . Robert A. Weersink, Brian C. Wilson, Arjen Bogaards, Photonic Therapeutics and Diagnostics III; Progress in Biomedical Optics and Imaging; vol.8 no.1; Proceedings of SPIE-The International Society for Optical Engineering; vol.6424 . 2007

机译：Tookad用于前列腺癌放疗后复发性前列腺癌的血管靶向光动力学研究：初步临床研究
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Clinical outcomes of First-line Abiraterone Acetate (AA) or Enzalutamide (E) for Metastatic Castration-Resistant Prostate Cancer (mCRPC) after Androgen Deprivation Therapy (ADT) + Docetaxel (D) or ADT alone for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) [O] . Edoardo Francini, Steven Yip, Shubidito Ahmed, -1

机译：一线醋酸阿比特龙（AA）或恩扎鲁胺（E）用于雄激素剥夺疗法（ADT）+多西他赛（D）或仅ADT用于转移性激素敏感性前列腺癌（mHSPC）的转移性去势抵抗性前列腺癌（mCRPC）的临床结果
7. The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy [O] . Jinge Zhao, Pengfei Shen, Guangxi Sun, 2017

机译：转移性阉割前列腺癌中前列腺内癌的预后意蕴及其在多西紫杉醇或阿维特酮作为一线治疗中的潜在预测价值

Prostate cancer: Patient-reported outcomes of first-line abiraterone therapy

摘要

著录项

相似文献

相关主题

期刊订阅